Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers
作者: Helen FowlerAurelien BelotLibby EllisCamille MaringeMiguel Angel Luque-FernandezEdmund Njeru NjagiNeal NavaniDiana SarfatiBernard Rachet
作者单位: 1Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, WC1E 7HT, London, UK
2Biomedical Research Institute of Granada, Non-Communicable and Cancer Epidemiology Group, University of Granada, Granada, Spain
3Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
4UCL Respiratory, University College London, London, UK
5Department of Thoracic Medicine, University College London Hospital, London, UK
6Department of Public Health, University of Otago, Wellington, New Zealand
刊名: BMC Cancer, 2020, Vol.20 (15), pp.1375-1380
来源数据库: Springer Nature Journal
DOI: 10.1186/s12885-019-6472-9
关键词: CancerComorbidityMultimorbidityDeprivationPrevalenceEnglandEpidemiology
英文摘要: Abstract(#br)Background(#br)The presence of comorbidity affects the care of cancer patients, many of whom are living with multiple comorbidities. The prevalence of cancer comorbidity, beyond summary metrics, is not well known. This study aims to estimate the prevalence of comorbid conditions among cancer patients in England, and describe the association between cancer comorbidity and socio-economic position, using population-based electronic health records. Methods(#br)We linked England cancer registry records of patients diagnosed with cancer of the colon, rectum, lung or Hodgkin lymphoma between 2009 and 2013, with hospital admissions records. A comorbidity was any one of fourteen specific conditions, diagnosed during hospital admission up to 6 years prior to cancer diagnosis. We...
全文获取路径: Springer Nature  (合作)
分享到:
来源刊物:
影响因子:3.333 (2012)

×